Brief: Vor Bio Reports Third Quarter 2022 Financial Results
10/11/2022 21:36
Nov 10 (Reuters) - Vor Biopharma Inc VOR.O :
* VOR BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES COMPANY UPDATE
* QTRLY LOSS PER SHARE $0.63
* Q3 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9nGLzt
Further company coverage: VOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning